Hem › Prostatacancer › Texas › League City
Kliniska studier för Prostatacancer i League City, TX
4 studier för Prostatacancer söker deltagare vid platser i och runt League City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekryterarFas 3
- UT MD Anderson - League City, League City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekryterarFas 3
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi bort
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekryterarFas 3
- MD Anderson League City, League City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekryterarFas 3
- MD Anderson League City, League City
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andra studier i League City
- Icke-småcellig lungcancer15 studier
- Bröstcancer12 studier
- Metastaserande cancer7 studier
- Ulcerös kolit6 studier
- Lungcancer6 studier
- Kolorektal cancer6 studier
- Cancer (alla typer)5 studier
- Äggstockscancer5 studier
- Stroke5 studier
- Blåscancer4 studier
- Plattenepitelcancer i huvud och hals4 studier
- Post-COVID-tillstånd (Long COVID)3 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.